YPS-19998-01189
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 895 / NV
- Registered
- 2021-07-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-11
Registered in v-safe
-
2021-07-11
Dose 1 — Pfizer-BioNTech
- 2021-07-11
- 2021-07-12
- 2021-07-14
- 2021-07-15
- 2021-07-27
-
2021-08-01
Dose 2 — Pfizer-BioNTech
- 2021-08-01
- 2021-08-02
- 2021-08-03
- 2021-08-08
- 2021-08-15
- 2021-08-24
- 2021-09-14
-
2022-01-31
Survey response — 6 months, dose 2MedDRA: Malaise, SARS-CoV-2 test positive — Feeling: FairFree text: Covid symptoms starting 1/26 Covid test positive 1/28MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-11 | Pfizer-BioNTech | No |
| 2 | 2021-08-01 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2
Symptoms: Covid symptoms starting 1/26 Covid test positive 1/28
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release